Skip to main content
. 2021 Mar 22;12:200. doi: 10.1186/s13287-021-02251-7

Fig. 3.

Fig. 3

Engineered activatory receptors of NK cells strengthen NK cells in tumor killing. CAR redirect tumor cell-specific NK cells to bind to their specific target on the surface of the cancer cell, resulting in NK cell activation, cytolytic factors secretion, and tumor lysis